Sun A. Kim

Sun A. Kim

Auto-generated profile, based on publicly available information

Sun A. Kim

Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2013 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
RNReiko Nishihara
Reiko Nishihara
KWKana Wu
Kana Wu
PLPaul Lochhead
Paul Lochhead
TMTeppei Morikawa
Teppei Morikawa
XLXiaoyun Liao
Xiaoyun Liao
ACAndrew T. Chan
Andrew T. Chan
Colonoscopy and sigmoidoscopy provide protection against colorectal cancer, but the magnitude and duration of protection, particularly against cancer of the proximal colon, remain uncertain. We examined the association of the use of lower endoscopy (updated biennially from 1988 through 2008) with colorectal-cancer incidence (through June 2010) and colorectal-cancer mortality (through June 2012) among participants in the Nurses' Health Study and the Health Professionals Follow-up Study. Among 88,902 participants followed over a period of 22 years, we documented 1815 incident colorectal cancers and 474 deaths from colorectal cancer. With endoscopy as compared with no endoscopy, multivariate hazard ratios for colorectal cancer were 0.57 (95% confidence interval [CI], 0.45 to 0.72) after polypectomy, 0.60 (95% CI, 0.53 to 0.68) after negative sigmoidoscopy, and 0.44 (95% CI, 0.38 to 0.52) after negative colonoscopy. Negative colonoscopy was associated with a reduced incidence of proximal colon cancer (multivariate hazard ratio, 0.73; 95% CI, 0.57 to 0.92). Multivariate hazard ratios for death from colorectal cancer were 0.59 (95% CI, 0.45 to 0.76) after screening sigmoidoscopy and 0.32 (95% CI, 0.24 to 0.45) after screening colonoscopy. Reduced mortality from proximal colon cancer was observed after screening colonoscopy (multivariate hazard ratio, 0.47; 95% CI, 0.29 to 0.76) but not after sigmoidoscopy. As compared with colorectal cancers diagnosed in patients more than 5 years after colonoscopy or without any prior endoscopy, those diagnosed in patients within 5 years after colonoscopy were more likely to be characterized by the CpG island methylator phenotype (CIMP) (multivariate odds ratio, 2.19; 95% CI, 1.14 to 4.21) and microsatellite instability (multivariate odds ratio, 2.10; 95% CI, 1.10 to 4.02). Colonoscopy and sigmoidoscopy were associated with a reduced incidence of cancer of the distal colorectum; colonoscopy was also associated with a modest reduction in the incidence of proximal colon cancer. Screening colonoscopy and sigmoidoscopy were associated with reduced colorectal-cancer mortality; only colonoscopy was associated with reduced mortality from proximal colon cancer. Colorectal cancer diagnosed within 5 years after colonoscopy was more likely than cancer diagnosed after that period or without prior endoscopy to have CIMP and microsatellite instability. (Funded by the National Institutes of Health and others.)

1 January 2012 in Yonsei Medical Journal
Verified
Journal Article
Open access
MDMukul Divatia
Mukul Divatia
SKSun A Kim
Sun A Kim
JRJae Y. Ro
Jae Y. Ro
Immunoglobulin G4-related systemic disease (IgG4-RSD) is a recently defined emerging entity characterized by a diffuse or mass forming inflammatory reaction rich in IgG4-positive plasma cells associated with fibrosclerosis and obliterative phlebitis. IgG4-RSD usually affects middle aged and elderly patients, with a male predominance. It is associated with an elevated serum titer of IgG4, which acts as a marker for this recently characterized entity. The prototype is IgG4-related sclerosing pancreatitis or autoimmune pancreatitis (AIP). Other common sites of involvement are the hepatobiliary tract, salivary gland, orbit, and lymph node, however practically any organ can be involved, including upper aerodigestive tract, lung, aorta, mediastinum, retroperitoneum, soft tissue, skin, central nervous system, breast, kidney, and prostate. Fever or constitutional symptoms usually do not comprise part of the clinical picture. Laboratory findings detected include raised serum globulin, IgG and IgG4. An association with autoantibody detection (such as antinuclear antibodies and rheumatoid factor) is seen in some cases. Steroid therapy comprises the mainstay of treatment. Disease progression with involvement of multiple organ-sites may be encountered in a subset of cases and may follow a relapsing-remitting course. The principal histopathologic findings in several extranodal sites include lymphoplasmacytic infiltration, lymphoid follicle formation, sclerosis and obliterative phlebitis, along with atrophy and destruction of tissues. Immunohistochemical staining shows increased IgG4+ cells in the involved tissues (>50 per high-power field, with IgG4/IgG ratio >40%). IgG4-RSD may potentially be rarely associated with the development of lymphoma and carcinoma. However, the nature and pathogenesis of IgG4-RSD are yet to be fully elucidated and provide immense scope for further studies.

1 January 2013 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
ELEun Lee
Eun Lee
JSJu-Hee Seo
Ju-Hee Seo
HKHyung Young Kim
Hyung Young Kim
JYJinho Yu
Jinho Yu
WJWon-Kyoung Jhang
Won-Kyoung Jhang
SHSoo-Jong Hong
Soo-Jong Hong
Lee E, et al. J Korean Med Sci. 2013 Jun;28(6):915-923. http://dx.doi.org/10.3346/jkms.2013.28.6.915

1 August 2011 in Human Pathology
Verified
Journal Article
Closed access
SKSun A. Kim
Sun A. Kim
SLSang-Ryung Lee
Sang-Ryung Lee
JHJooryung Huh
Jooryung Huh
SSSteven S. Shen
Steven S. Shen
JRJae Y. Ro
Jae Y. Ro

1 January 2013 in Journal of Korean Neurosurgical Society
Verified
Journal Article
Open access
SLSungryong Lim
Sungryong Lim
JKJeong Hoon Kim
Jeong Hoon Kim
SKSun A Kim
Sun A Kim
EPEun Suk Park
Eun Suk Park
YRYoung Shin Ra
Young Shin Ra
CKChang Jin Kim
Chang Jin Kim
Pleomorphic xanthoastrocytoma (PXA) is a rare primary low-grade astrocytic tumor classified as WHO II. It is generally benign, but disease progression and malignant transformation have been reported. Prognostic factors for PXA and optimal therapies are not well known. The study period was January 2000 to March 2012. Data on MR findings, histology, surgical extents and adjuvant therapies were reviewed in twenty-two patients diagnosed with PXA. The frequent symptoms of PXA included seizures, headaches and neurologic deficits. Tumors were most common in the temporal lobe followed by frontal, parietal and occipital lobes. One patient who died from immediate post-operative complications was excluded from the statistical analysis. Of the remaining 21 patients, 3 (14%) died and 7 (33%) showed disease progression. Atypical tumor location (p<0.001), peritumoral edema (p=0.022) and large tumor size (p=0.048) were correlated with disease progression, however, Ki-67 index and necrosis were not statistically significant. Disease progression occurred in three (21%) of 14 patients who underwent GTR, compared with 4 (57%) of 7 patients who did not undergo GTR, however, it was not statistically significant. Ten patients received adjuvant radiotherapy and the tumors were controlled in 5 of these patients. The prognosis for PXA is good; in our patients overall survival was 84%, and event-free survival was 59% at 3 years. Atypical tumor location, peritumoral edema and large tumor size are significantly correlated with disease progression. GTR may provide prolonged disease control, and adjuvant radiotherapy may be beneficial, but further study is needed.

1 January 2012 in Journal of the Korean Society of Coloproctology
Verified
Journal Article
Open access
PDF file
MKMin Ae Keum
Min Ae Keum
SLSeok-Byung Lim
Seok-Byung Lim
SKSun A Kim
Sun A Kim
YYYong Sik Yoon
Yong Sik Yoon
CKChan Wook Kim
Chan Wook Kim
CKChan-wook Kim
Chan-wook Kim
Keum MA, et al. J Korean Soc Coloproctol. 2012 Feb;28(1):49-55. http://dx.doi.org/10.3393/jksc.2012.28.1.49